BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1049 related articles for article (PubMed ID: 26479923)

  • 1. High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.
    Gao H; Korn JM; Ferretti S; Monahan JE; Wang Y; Singh M; Zhang C; Schnell C; Yang G; Zhang Y; Balbin OA; Barbe S; Cai H; Casey F; Chatterjee S; Chiang DY; Chuai S; Cogan SM; Collins SD; Dammassa E; Ebel N; Embry M; Green J; Kauffmann A; Kowal C; Leary RJ; Lehar J; Liang Y; Loo A; Lorenzana E; Robert McDonald E; McLaughlin ME; Merkin J; Meyer R; Naylor TL; Patawaran M; Reddy A; Röelli C; Ruddy DA; Salangsang F; Santacroce F; Singh AP; Tang Y; Tinetto W; Tobler S; Velazquez R; Venkatesan K; Von Arx F; Wang HQ; Wang Z; Wiesmann M; Wyss D; Xu F; Bitter H; Atadja P; Lees E; Hofmann F; Li E; Keen N; Cozens R; Jensen MR; Pryer NK; Williams JA; Sellers WR
    Nat Med; 2015 Nov; 21(11):1318-25. PubMed ID: 26479923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation.
    Kang HN; Choi JW; Shim HS; Kim J; Kim DJ; Lee CY; Hong MH; Park SY; Park AY; Shin EJ; Lee SY; Pyo KH; Yun MR; Choi HM; Lee SS; Kim SY; Lee H; Paik S; Cho BC; Lee JG; Kim HR
    Lung Cancer; 2018 Oct; 124():168-178. PubMed ID: 30268457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative profiling of the novel epothilone, sagopilone, in xenografts derived from primary non-small cell lung cancer.
    Hammer S; Sommer A; Fichtner I; Becker M; Rolff J; Merk J; Klar U; Hoffmann J
    Clin Cancer Res; 2010 Mar; 16(5):1452-65. PubMed ID: 20179216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-derived xenografts of non-small-cell lung cancer: a pre-clinical model to evaluate adjuvant chemotherapy?
    Merk J; Rolff J; Becker M; Leschber G; Fichtner I
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):454-9. PubMed ID: 19502076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical efficacy of the camptothecin-polymer conjugate IT-101 in multiple cancer models.
    Schluep T; Hwang J; Cheng J; Heidel JD; Bartlett DW; Hollister B; Davis ME
    Clin Cancer Res; 2006 Mar; 12(5):1606-14. PubMed ID: 16533788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating patient-derived colorectal cancer xenografts as preclinical models by comparison with patient clinical data.
    Nunes M; Vrignaud P; Vacher S; Richon S; Lièvre A; Cacheux W; Weiswald LB; Massonnet G; Chateau-Joubert S; Nicolas A; Dib C; Zhang W; Watters J; Bergstrom D; Roman-Roman S; Bièche I; Dangles-Marie V
    Cancer Res; 2015 Apr; 75(8):1560-6. PubMed ID: 25712343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy?
    Merk J; Rolff J; Dorn C; Leschber G; Fichtner I
    Eur J Cardiothorac Surg; 2011 Jul; 40(1):e29-33. PubMed ID: 21420313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary human non-small cell lung and pancreatic tumorgraft models--utility and applications in drug discovery and tumor biology.
    Calles A; Rubio-Viqueira B; Hidalgo M
    Curr Protoc Pharmacol; 2013 Jun; Chapter 14():Unit 14.26. PubMed ID: 23744711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-derived tumor xenograft models for melanoma drug discovery.
    Harris AL; Joseph RW; Copland JA
    Expert Opin Drug Discov; 2016 Sep; 11(9):895-906. PubMed ID: 27454070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of human Alu sequences by real-time PCR--an improved method to measure therapeutic efficacy of anti-metastatic drugs in human xenotransplants.
    Schneider T; Osl F; Friess T; Stockinger H; Scheuer WV
    Clin Exp Metastasis; 2002; 19(7):571-82. PubMed ID: 12498386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
    Lee FY; Borzilleri R; Fairchild CR; Kim SH; Long BH; Reventos-Suarez C; Vite GD; Rose WC; Kramer RA
    Clin Cancer Res; 2001 May; 7(5):1429-37. PubMed ID: 11350914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antitumor efficacy of telomerase-selective oncolytic adenoviral agent OBP-401 with docetaxel: preclinical evaluation of chemovirotherapy.
    Fujiwara T; Kagawa S; Kishimoto H; Endo Y; Hioki M; Ikeda Y; Sakai R; Urata Y; Tanaka N; Fujiwara T
    Int J Cancer; 2006 Jul; 119(2):432-40. PubMed ID: 16477640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-derived tumour xenografts as models for breast cancer drug development.
    Marangoni E; Poupon MF
    Curr Opin Oncol; 2014 Nov; 26(6):556-61. PubMed ID: 25188472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models.
    Zhang J; Zhang L; Su X; Li M; Xie L; Malchers F; Fan S; Yin X; Xu Y; Liu K; Dong Z; Zhu G; Qian Z; Tang L; Schöttle J; Zhan P; Ji Q; Kilgour E; Smith PD; Brooks AN; Thomas RK; Gavine PR
    Clin Cancer Res; 2012 Dec; 18(24):6658-67. PubMed ID: 23082000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a precision medicine pipeline to identify personalized treatments for colorectal cancer.
    Altunel E; Roghani RS; Chen KY; Kim SY; McCall S; Ware KE; Shen X; Somarelli JA; Hsu DS
    BMC Cancer; 2020 Jun; 20(1):592. PubMed ID: 32580713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preclinical screening of chemotherapeutic and endocrine agents using human tumor xenografts--nude mouse system].
    Kubota T; Ishibiki K; Abe O
    Gan To Kagaku Ryoho; 1991 Jul; 18(9):1439-47. PubMed ID: 1854214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput screening of human leukemia xenografts to identify dexamethasone sensitizers.
    Toscan CE; Failes T; Arndt GM; Lock RB
    J Biomol Screen; 2014 Dec; 19(10):1391-401. PubMed ID: 25104793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling of Patient-Derived Xenografts in Colorectal Cancer.
    Katsiampoura A; Raghav K; Jiang ZQ; Menter DG; Varkaris A; Morelli MP; Manuel S; Wu J; Sorokin AV; Rizi BS; Bristow C; Tian F; Airhart S; Cheng M; Broom BM; Morris J; Overman MJ; Powis G; Kopetz S
    Mol Cancer Ther; 2017 Jul; 16(7):1435-1442. PubMed ID: 28468778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a preclinical model for assessment of drug efficacy in melanoma.
    Delyon J; Varna M; Feugeas JP; Sadoux A; Yahiaoui S; Podgorniak MP; Leclert G; Dorval SM; Dumaz N; Soulie J; Janin A; Mourah S; Lebbé C
    Oncotarget; 2016 Mar; 7(11):13069-81. PubMed ID: 26909610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.